Abstract:Maintenance of energy balance between intake and expenditure is a prerequisite of human health, disrupted in severe metabolic diseases, such as obesity and type 2 diabetes (T2D), mainly due to accumulation of white adipose tissue (WAT). WAT undergoes a morphological and energetic remodelling toward brown adipose tissue (BAT) and the BAT activation has anti-obesity potential. The mechanisms or the regulatory factors able to activate BAT thermogenesis have been only partially deciphered. Identifying novel regulators of BAT induction is a question of great importance for fighting obesity and T2D. Here, we evaluated the role of Hif3α in murine pre-adipocyte 3T3-L1 cell line, a versatile and well characterized biological model of adipogenesis, by gain- and loss-of function approaches and in thermogenesis-induced model in vivo . HIF3A is regulated by inflammation, it modulates lypolysis in adipose tissue of obese adults, but its role in energy metabolism has not previously been investigated. We characterized gene and protein expression patterns of adipogenesis and metabolic activity in vitro and mechanistically in vivo . Overexpression of Hif3α in differentiating adipocytes increases white fat cells, whereas silencing of Hif3α promotes “browning” of white cells, activating thermogenesis through upregulation of Ucp1, Elovl3, Prdm16, Dio2 and Ppargc1a genes. Investigating cell metabolism, Seahorse Real-Time Cell Metabolism Analysis showed that silencing of Hif3α resulted in a significant increase of mitochondrial uncoupling with a concomitant increase in acetyl-CoA metabolism and Sirt1 and Sirt3 expression. The causal Hif3α/Ucp1 inverse relation has been validated in Cannabinoid receptor 1 (CB1) knockout, a thermogenesis-induced model in vivo . Our data indicate that Hif3α inhibition triggers “browning” of white adipocytes activating the beneficial thermogenesis rewiring energy metabolism in vitro and in vivo . HIF3A is a novel player that controls the energy metabolism with potential applications in developing therapy to fight metabolic disorders, as obesity, T2D and ultimately cancer.

Thermogenesis: Transferrin Receptor 1 Regulates Thermogenic Capacity and Cell Fate in Brown/Beige Adipocytes (adv. Sci. 12/2020)

Transferrin Receptor 1 Regulates Thermogenic Capacity and Cell Fate in Brown/Beige Adipocytes.

Transferrin Receptor Functionally Marks Thermogenic Adipocytes

Cold-Inducible Klf9 Regulates Thermogenesis of Brown and Beige Fat

Molecular and cellular regulation of thermogenic fat

Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism

Foxp1 controls brown/beige adipocyte differentiation and thermogenesis through regulating β3-AR desensitization

Molecular Regulation of Thermogenic Mechanisms in Beige Adipocytes

BAF60a Orchestrates Thermogenic Chromatin Accessibility in Brown Fat

BAF60a Deficiency Uncouples Chromatin Accessibility and Cold Sensitivity from White Fat Browning.

Overexpression of Adiponectin Receptor 1 Inhibits Brown and Beige Adipose Tissue Activity in Mice

Regulation of Adipose Thermogenesis and its Critical Role in Glucose and Lipid Metabolism

CLCF1 signaling restrains thermogenesis and disrupts metabolic homeostasis by inhibiting mitochondrial biogenesis in brown adipocytes

Inhibition of a Novel CLK1-THRAP3-PPARγ Axis Improves Insulin Sensitivity

HIF3A Inhibition Triggers Browning of White Adipocytes via Metabolic Rewiring

Recruitment of Thermogenic Fat: Trigger of Fat Burning

A miR-327–FGF10–FGFR2-mediated autocrine signaling mechanism controls white fat browning

Opioid Growth Factor Receptor Promotes Adipose Tissue Thermogenesis Via Enhancing Lipid Oxidation

Adipocyte IRE1α promotes PGC1α mRNA decay and restrains adaptive thermogenesis

Local hyperthermia therapy induces browning of white fat and treats obesity

FOXP4 differentially controls cold-induced beige adipocyte differentiation and thermogenesis